The Supreme Court Takes on Zicam - What About Vaccines?
Do you ever find yourself wondering when the media will look at vaccines with the same skepticism as it does other medications?
After watching Anderson Cooper of CNN go after Dr. Andrew Wakefield with more anger than if he'd been questioning a dictator who'd killed millions, I'm not really holding my breath for the media to do their job.
I'm a little more hopeful for the Supreme Court. In a January 13, 2011 editorial for The New York Times entitled "The Anosmia Case" HERE the Times told of a very interesting case before the Supreme Court in which the justices displayed an admirable amount of intellectual curiousity and just plain common sense.
It's one of those cases in which you get to the end and ask yourself, are the lawyers really making that argument? Here are the facts.
Zicam, a homeopathic cold remedy was marketed by a company called Matrixx Initiatives. The company received complaints from 23 users of the product claiming they'd lost their sense of smell, a condition known as anosmia. "Good Morning America" aired a piece questioning the safety of Zicam and as a result the price of Matrixx's stock fell 24 percent. The shareholders sued, saying the company should have warned investors about the problems and potential lawsuits.
According to The New York Times, "The company complained that it didn't have to, arguing that the complaints had no scientific basis, that any loss of smell should be blamed on illness and that the number of complaints was not statistically significant." Sounds similar to how the pharmaceutical companies respond to complaints regarding vaccine injury, doesn't it? If it's not "proven" we don't have to tell you the company claimed.
Continue reading "The Supreme Court Takes on Zicam - What About Vaccines?" »